← Back to headlines
Braveheart Raises Over $382 Million in IPO
Cardiac drug developer Braveheart successfully completed its Initial Public Offering, securing more than $382 million in funding.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
First Electric Ferrari Sells for Record $40 Million at Auction
19m ago
Meta Faces Trillion-Dollar Lawsuit Threatening Instagram and Facebook Future
32m ago
Japan's Economy Grows 1.1% in Second Quarter, Below Expectations
40m ago
Malaysia Airlines Pilots Cleared in Drug Tests, Cabin Crew Screening Next
41m ago